A potential role for resveratrol as a radiation sensitizer for melanoma treatment

Radiotherapy (XRT) is used to improve local control of melanoma and for palliation of metastatic disease. Clinical use of XRT for melanoma is often limited by extent of disease and the relative radioresistance of melanoma may limit the effectiveness of XRT. Several groups have previously shown that resveratrol (RSV) enhances radiation sensitivity in radioresistant prostate cancer cell lines.
In a study published on the Journal of Surgical Research, Vol, 183, Issue 2, Researchers from the University of Missouri School of Medicine, Columbia, USA, have evaluated the effects of XRT in combination with RSV on radioresistant melanoma lines, SK-Mel-5 and HTB-65, by assessment of proliferation and apoptosis. Clonogenic assay, comparison of proliferating cell nuclear antigen staining, Quick Cell Proliferation assay, terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) staining and caspase-3 activity assay were used to assess proliferation and apoptosis, as appropriate.
They found that the percentage of colonies, proliferating cell nuclear antigen + cells and the optical density value of melanoma cells were decreased after addition of RSV to XRT (XRT/RSV). TUNEL + cells and the relative caspase-3 activity in melanoma cells were increased after addition of RSV to XRT (XRT/RSV). We investigated the possible molecular mechanisms of decreased proliferation and increased apoptosis by using reverse transcriptase-polymerase chain reaction and immunohistochemical staining. The anti-proliferative effect of XRT/RSV correlated with decreased expression of pro-proliferative molecule cyclin B, cyclin D, cdk2 and cdk4. The pro-apoptotic effect of XRT/RSV correlated with decreased expression of the anti-apoptotic molecule FLIP, Bcl-2, and survivin.
These data suggest that RSV enhances radiation sensitivity of melanoma cells by inhibiting proliferation and promoting apoptosis. Resveratrol may have a potential role as a radiation sensitizer for melanoma treatment.


Amorim’s FSC journey leads towards a responsible future

  Amorim Cork Italy has long embarked on a path of sustainability that is unparalleled. If maintaining technological advancements, in order to defend the wines...

Your tailor-made ingredients partner

  Di Bartolo: an Italian company with an international scope   Since 1951 Di Bartolo has been synonymous with innovation and quality in the field of production...

Highest safety level for viscous and liquid products

  Dypipe: the new X-ray inspection system from Minebea Intec   Dypipe was developed specifically for producers of pumped goods. The X-ray inspection system from Minebea Intec,...



13-17/10/2023 - MILANO
18-19/10/2023 - VERONA
18-20/10/2023 - ROMA
22-26/10/2023 - MONACO, GERMANIA
24-27/10/2023 - PARMA
7-9/11/2023 - DUBAI, EAU
8-9/11/2023 - AUXERRE, FRANCIA
22-23/11/2023 - MILANO
22-24/11/2023 - SHANGHAI, CINA
28-30/11/2023 - NORIMBERGA, GERMANIA
20-24/01/2024 - RIMINI
28-31/01/2024 - COLONIA, GERMANIA
7-9/02/2024 - BERLINO, GERMANIA
18-20/02/2024 - RIMINI
10-12/03/2024 - DÜSSELDORF, GERMANIA
9-22/03/2024 - COLONIA, GERMANIA
7-10/05/2024 - PARMA
14-16/05/2024 - GINEVRA, SVIZZERA
28-30/05/2024 - MILANO
28-30/05/2024 PARMA
6-7/06/2024 - PARMA
12-15/06/2024 - BANGKOK, TAILANDIA
18-21/06/2024 - SHANGHAI, CINA